Latest Asx News

Artrya Limited has launched a A$15 million capital raising to fund the development and commercial rollout of its Salix AI-powered coronary artery disease diagnostic platform, targeting the lucrative US healthcare market.

LGI Limited reported a 7% rise in revenue and a 3% increase in EBITDA for H1 FY25, driven by expanded power generation capacity and higher landfill gas flows. However, net profit after tax declined by 22%, reflecting ongoing investment and market dynamics.

WAM Capital Limited has announced a six-month ordinary dividend of AUD 0.0775 per share, partially franked at 60%, payable on April 30, 2025. The company’s Dividend Reinvestment Plan remains fully available to shareholders.

Artrya Limited has secured A$15 million through a two-tranche placement aimed at accelerating regulatory approvals and commercial rollout of its Salix® coronary artery disease diagnostic software in the US.

Tivan Limited has formalised a Resourcing Protocol Agreement with the Kimberley Land Council, setting a clear path to negotiate an Indigenous Land Use Agreement for its Speewah Project.

Suvo Strategic Minerals has extended its key take or pay Offtake Agreement with Chaozhou Chengcheng Industrial Co., Ltd, increasing minimum hydrous kaolin order volumes by 25% over five years, valued at approximately A$6.56 million.

Global Lithium Resources Limited has refreshed its board following the 2025 AGM, appointing Dr Dianmin Chen as Managing Director and CEO to spearhead strategic milestones at the Manna Lithium Project and restore investor confidence.

Abacus Storage King (ASK) reported a robust half-year performance for HY25, with net profit soaring to $67.8 million and key operating metrics showing solid growth. The company’s strategic acquisitions, development pipeline, and platform initiatives underpin its confident outlook.

Abacus Storage King reported a striking turnaround with a $67.8 million net profit for H1 2024, up from just $0.4 million a year earlier, alongside a raised interim distribution reflecting robust growth in the self-storage sector.

EQ Resources Ltd updates investors on its proposed acquisition of Tungsten Metals Group, highlighting completed due diligence but pending definitive agreements as discussions continue beyond the exclusivity period.

Touch Ventures Limited reported a substantial $24.9 million net loss for 2024, driven by impairments in legacy investments, while strategically pivoting with new stakes in Tixel and Reshop and welcoming Gannet Capital as a major shareholder.

Imugene’s Phase 1b trial of azer-cel, an off-the-shelf CD19 CAR T therapy, reports a 57% complete response rate in heavily pretreated diffuse large B-cell lymphoma patients, signaling a promising new option in a challenging cancer landscape.